SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billkirn who wrote (5212)8/26/1998 2:08:00 PM
From: Izzy  Read Replies (1) of 6136
 
I think that the IMNR people are banking on an eventual buyout by AGPH. Then, after AGPH splits into 2 fragments and DD gets some money after unloading Conoco, then I'm guessing that AGPH will become a direct buyout candidate (I don't believe in the "poison pill"; everybody has a price, IMO). So, I'm staying long on AGPH and IMNR, and, in fact, may buy some more. IMNR has had a recent strong buy recommendation (Prudential Securities) with a target price of 27. PS: Do you think that Pat Robertson is going to pray away the hurricane from the Virginia Beach area?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext